Stanford chemists develop `ultra-sensitive test' for cancers

| TNN |
Coming, super sensitive test to detect cancers, HIV (Getty Images)Coming, super sensitive test to detect cancers, HIV (Getty Images)
It is usually said that early detection of cancer could lead to effective treatment, but a lot depends on the patient undergoing screening at the right time.
If a new method developed by Stanford University researchers clicks in a soon-to-be launched clinical trial, tests will soon become more sensitive in picking up cancer cells than existing tests.

"When a disease - whether a cancer or a virus like HIV - begins growing in the body, the immune system responds by producing antibodies. Fishing these antibodies or related biomarkers out of the blood is one way that scientists infer the presence of a disease. This involves designing a molecule that the biomarker will bind to, and which is adorned with an identifying "flag." Through a series of specialized chemical reactions, known as an immunoassay, researchers can isolate that flag, and the biomarker bound to it, to provide a proxy measurement of the disease," said a press release sent out by the university.

Latest Comment

Cancer vaccine?Communal Award